Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Psoriatic Arthritis Therapeutics Drug Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Psoriatic Arthritis Therapeutics Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Psoriatic Arthritis Therapeutics Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Type
    • 1.4.2 NF Inhibitors
    • 1.4.3 Interleukin Inhibitors
    • 1.4.4 PDE4 Inhibitors
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Coronavirus Disease 2019 (Covid-19): Psoriatic Arthritis Therapeutics Drug Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Psoriatic Arthritis Therapeutics Drug Industry
      • 1.6.1.1 Psoriatic Arthritis Therapeutics Drug Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Psoriatic Arthritis Therapeutics Drug Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Psoriatic Arthritis Therapeutics Drug Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Psoriatic Arthritis Therapeutics Drug Market Size Estimates and Forecasts
    • 2.1.1 Global Psoriatic Arthritis Therapeutics Drug Revenue 2015-2026
    • 2.1.2 Global Psoriatic Arthritis Therapeutics Drug Sales 2015-2026
  • 2.2 Psoriatic Arthritis Therapeutics Drug Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Psoriatic Arthritis Therapeutics Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Psoriatic Arthritis Therapeutics Drug Competitor Landscape by Players

  • 3.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers
    • 3.1.1 Psoriatic Arthritis Therapeutics Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers
    • 3.2.1 Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Psoriatic Arthritis Therapeutics Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Psoriatic Arthritis Therapeutics Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Drug Revenue in 2019
    • 3.2.5 Global Psoriatic Arthritis Therapeutics Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Psoriatic Arthritis Therapeutics Drug Price by Manufacturers
  • 3.4 Psoriatic Arthritis Therapeutics Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Psoriatic Arthritis Therapeutics Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Psoriatic Arthritis Therapeutics Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Psoriatic Arthritis Therapeutics Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2015-2020)
    • 4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2015-2020)
    • 4.1.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Psoriatic Arthritis Therapeutics Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Psoriatic Arthritis Therapeutics Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Psoriatic Arthritis Therapeutics Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2015-2020)
    • 5.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue by Application (2015-2020)
    • 5.1.3 Psoriatic Arthritis Therapeutics Drug Price by Application (2015-2020)
  • 5.2 Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Psoriatic Arthritis Therapeutics Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Psoriatic Arthritis Therapeutics Drug by Country
    • 6.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales by Country
    • 6.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
  • 6.3 North America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Psoriatic Arthritis Therapeutics Drug by Country
    • 7.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales by Country
    • 7.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
  • 7.3 Europe Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug by Region
    • 8.1.1 Asia Pacific Psoriatic Arthritis Therapeutics Drug Sales by Region
    • 8.1.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Psoriatic Arthritis Therapeutics Drug by Country
    • 9.1.1 Latin America Psoriatic Arthritis Therapeutics Drug Sales by Country
    • 9.1.2 Latin America Psoriatic Arthritis Therapeutics Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
  • 9.3 Central & South America Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Country
    • 10.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Country
    • 10.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description, Business Overview and Total Revenue
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.1.5 AbbVie Recent Development
  • 11.2 Janssen Biotech
    • 11.2.1 Janssen Biotech Corporation Information
    • 11.2.2 Janssen Biotech Description, Business Overview and Total Revenue
    • 11.2.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.2.5 Janssen Biotech Recent Development
  • 11.3 Novartis
    • 11.3.1 Novartis Corporation Information
    • 11.3.2 Novartis Description, Business Overview and Total Revenue
    • 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Novartis Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.3.5 Novartis Recent Development
  • 11.4 Amgen
    • 11.4.1 Amgen Corporation Information
    • 11.4.2 Amgen Description, Business Overview and Total Revenue
    • 11.4.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Amgen Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.4.5 Amgen Recent Development
  • 11.5 CELGENE CORPORATION
    • 11.5.1 CELGENE CORPORATION Corporation Information
    • 11.5.2 CELGENE CORPORATION Description, Business Overview and Total Revenue
    • 11.5.3 CELGENE CORPORATION Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.5.5 CELGENE CORPORATION Recent Development
  • 11.6 Pfizer
    • 11.6.1 Pfizer Corporation Information
    • 11.6.2 Pfizer Description, Business Overview and Total Revenue
    • 11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Pfizer Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.6.5 Pfizer Recent Development
  • 11.7 Eli Lilly
    • 11.7.1 Eli Lilly Corporation Information
    • 11.7.2 Eli Lilly Description, Business Overview and Total Revenue
    • 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Eli Lilly Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.7.5 Eli Lilly Recent Development
  • 11.8 UCB
    • 11.8.1 UCB Corporation Information
    • 11.8.2 UCB Description, Business Overview and Total Revenue
    • 11.8.3 UCB Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 UCB Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.8.5 UCB Recent Development
  • 11.9 Biogen
    • 11.9.1 Biogen Corporation Information
    • 11.9.2 Biogen Description, Business Overview and Total Revenue
    • 11.9.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Biogen Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.9.5 Biogen Recent Development
  • 11.10 Bristol-Myers Squibb
    • 11.10.1 Bristol-Myers Squibb Corporation Information
    • 11.10.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
    • 11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.10.5 Bristol-Myers Squibb Recent Development
  • 11.1 AbbVie
    • 11.1.1 AbbVie Corporation Information
    • 11.1.2 AbbVie Description, Business Overview and Total Revenue
    • 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 AbbVie Psoriatic Arthritis Therapeutics Drug Products Offered
    • 11.1.5 AbbVie Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Psoriatic Arthritis Therapeutics Drug Market Estimates and Projections by Region
    • 12.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Psoriatic Arthritis Therapeutics Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Psoriatic Arthritis Therapeutics Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Psoriatic Arthritis Therapeutics Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Psoriatic Arthritis Therapeutics Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Therapeutics Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Psoriatic Arthritis Therapeutics Drug market is segmented into
    NF Inhibitors
    Interleukin Inhibitors
    PDE4 Inhibitors
    Others

    Segment by Application, the Psoriatic Arthritis Therapeutics Drug market is segmented into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

    Regional and Country-level Analysis
    The Psoriatic Arthritis Therapeutics Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Psoriatic Arthritis Therapeutics Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Psoriatic Arthritis Therapeutics Drug Market Share Analysis
    Psoriatic Arthritis Therapeutics Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Psoriatic Arthritis Therapeutics Drug business, the date to enter into the Psoriatic Arthritis Therapeutics Drug market, Psoriatic Arthritis Therapeutics Drug product introduction, recent developments, etc.
    The major vendors covered:
    AbbVie
    Janssen Biotech
    Novartis
    Amgen
    CELGENE CORPORATION
    Pfizer
    Eli Lilly
    UCB
    Biogen
    Bristol-Myers Squibb

    Buy now